Glycomic analysis of gastric carcinoma cells discloses glycans as modulators of RON receptor tyrosine kinase activation in cancer

Biochimica et Biophysica Acta - General Subjects

Volumn 1860, Issue 8, 2016, Pages 1795-1808

  Mereiter, Stefan ^a,b   Magalhães, Ana ^a,b   Adamczyk, Barbara ^c   Jin, Chunsheng ^c   Almeida, Andreia ^d,e   Drici, Lylia ^f   Ibáñez Vea, Maria ^f   Gomes, Catarina ^a,b   Ferreira, José A ^a,b,g   Afonso, Luis P ^g   Santos, Lúcio L ^g   Larsen, Martin R ^f   Kolarich, Daniel ^d   Karlsson, Niclas G ^c   Reis, Celso A ^a,b,h  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d MAX PLANCK INSTITUTE OF COLLOIDS AND INTERFACES   (Germany)

^e FREIE UNIVERSITÄT BERLIN   (Germany)

^f UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^g PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^h University of Porto   (Portugal)

Author keywords

Gastric cancer; Glycome; RON; Sialome; Sialyl Lewis X (SLeX); ST3GAL4

Indexed keywords

GLYCAN DERIVATIVE; PROTEIN TYROSINE KINASE; RON RECEPTOR TYROSINE KINASE; SIALYLTRANSFERASE; SIALYLTRANSFERASE ST3GAL4; UNCLASSIFIED DRUG; BETA-GALACTOSIDE ALPHA-2,3-SIALYLTRANSFERASE; CD15 ANTIGEN; POLYSACCHARIDE; RON PROTEIN; SIALYL LEWIS X ANTIGEN; TUMOR PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME GLYCOSYLATION; ENZYME LOCALIZATION; GASTRIC CANCER CELL LINE; GENE ACTIVATION; GENE EXPRESSION REGULATION; GLYCOBIOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; ONCOGENE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SIALYLATION; ST3GAL4 GENE; UPREGULATION; BIOSYNTHESIS; GENETICS; METABOLISM; STOMACH TUMOR;

ANTIGENS, CD15; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOMICS; HUMANS; NEOPLASM PROTEINS; POLYSACCHARIDES; RECEPTOR PROTEIN-TYROSINE KINASES; SIALYLTRANSFERASES; STOMACH NEOPLASMS;

EID: 84952685671     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2015.12.016     Document Type: Article

References (80)

1. R.L. Siegel, K.D. Miller, and A. Jemal Cancer statistics, 2015 CA Cancer J. Clin. 65 2015 5 29
2. M. May Statistics: attacking an epidemic Nature 509 2014 S50 S51
3. J. Ferlay, E. Steliarova-Foucher, J. Lortet-Tieulent, S. Rosso, J.W. Coebergh, H. Comber, D. Forman, and F. Bray Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012 Eur. J. Cancer 49 2013 1374 1403
4. M. Carpelan-Holmstrom, J. Louhimo, U.H. Stenman, H. Alfthan, and C. Haglund CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers Anticancer Res. 22 2002 2311 2316
5. C.A. Reis, H. Osorio, L. Silva, C. Gomes, and L. David Alterations in glycosylation as biomarkers for cancer detection J. Clin. Pathol. 63 2010 322 329
6. A. Varki, R. Kannagi, and B.P. Toole Glycosylation Changes in Cancer A. Varki, R.D. Cummings, J.D. Esko, H.H. Freeze, P. Stanley, C.R. Bertozzi, G.W. Hart, M.E. Etzler, Essentials of Glycobiology 2009 Cold Spring Harbor NY
7. S.S. Pinho, and C.A. Reis Glycosylation in cancer: mechanisms and clinical implications Nat. Rev. Cancer 15 2015 540 555
8. K.M. Wong, T.J. Hudson, and J.D. McPherson Unraveling the genetics of cancer: genome sequencing and beyond Annu. Rev. Genomics Hum. Genet. 12 2011 407 430
9. R.L. Schilsky Personalized medicine in oncology: the future is now Nat. Rev. Drug Discov. 9 2010 363 366
10. C. Sawyers Targeted cancer therapy Nature 432 2004 294 297
11. A. Arora, and E.M. Scholar Role of tyrosine kinase inhibitors in cancer therapy J. Pharmacol. Exp. Ther. 315 2005 971 979
12. H.P. Yao, Y.Q. Zhou, R. Zhang, and M.H. Wang MSP-RON signalling in cancer: pathogenesis and therapeutic potential Nat. Rev. Cancer 13 2013 466 481
13. A.S. Carvalho, A. Harduin-Lepers, A. Magalhaes, E. Machado, N. Mendes, L.T. Costa, R. Matthiesen, R. Almeida, J. Costa, and C.A. Reis Differential expression of alpha-2,3-sialyltransferases and alpha-1,3/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells Int. J. Biochem. Cell Biol. 42 2010 80 89
14. T. Conze, A.S. Carvalho, U. Landegren, R. Almeida, C.A. Reis, L. David, and O. Soderberg MUC2 mucin is a major carrier of the cancer-associated sialyl-Tn antigen in intestinal metaplasia and gastric carcinomas Glycobiology 20 2010 199 206
15. P. Lauren The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification Acta Pathol. Microbiol. Scand. 64 1965 31 49
16. B.L. Schulz, N.H. Packer, and N.G. Karlsson Small-scale analysis of O-linked oligosaccharides from glycoproteins and mucins separated by gel electrophoresis Anal. Chem. 74 2002 6088 6097
17. L. Royle, C.M. Radcliffe, R.A. Dwek, and P.M. Rudd Detailed structural analysis of N-glycans released from glycoproteins in SDS-PAGE gel bands using HPLC combined with exoglycosidase array digestions Methods Mol. Biol. 347 2006 125 143
18. 2, SIMAC, and HILIC J. Proteomics 75 2012 5749 5761
19. M.N. Melo-Braga, M. Ibanez-Vea, M.R. Larsen, and K. Kulej Comprehensive protocol to simultaneously study protein phosphorylation, acetylation, and N-linked sialylated glycosylation Methods Mol. Biol. 1295 2015 275 292
20. V. Schwammle, I.R. Leon, and O.N. Jensen Assessment and improvement of statistical tools for comparative proteomics analysis of sparse data sets with few experimental replicates J. Proteome Res. 12 2013 3874 3883
21. A. Harduin-Lepers, M.A. Krzewinski-Recchi, F. Colomb, F. Foulquier, S. Groux-Degroote, and P. Delannoy Sialyltransferases functions in cancers Front. Biosci. 4 2012 499 515
22. K. Sasaki, E. Watanabe, K. Kawashima, S. Sekine, T. Dohi, M. Oshima, N. Hanai, T. Nishi, and M. Hasegawa Expression cloning of a novel Gal beta (1-3/1-4) GlcNAc alpha 2,3-sialyltransferase using lectin resistance selection J. Biol. Chem. 268 1993 22782 22787
23. H. Kitagawa, and J.C. Paulson Cloning of a novel alpha 2,3-sialyltransferase that sialylates glycoprotein and glycolipid carbohydrate groups J. Biol. Chem. 269 1994 1394 1401
24. C. Gomes, H. Osorio, M.T. Pinto, D. Campos, M.J. Oliveira, and C.A. Reis Expression of ST3GAL4 leads to SLe(x) expression and induces c-Met activation and an invasive phenotype in gastric carcinoma cells PLoS One 8 2013 e66737
25. S. Mereiter, A. Magalhães, B. Adamczyk, C. Jin, A. Almeida, L. Drici, M. Ibanez-Vea, M.R. Larsen, D. Kolarich, N.G. Karlsson, and C.A. Reis Glycomic and sialoproteomic data of gastric carcinoma cells overexpressing ST3GAL4 Data in Brief 2015 (submitted for publication)
26. A. Ishizuka, Y. Hashimto, R. Naka, M. Kinoshita, K. Kakehi, J. Seino, Y. Funakoshi, T. Suzuki, A. Kameyama, and H. Narimatsu Accumulation of free complex-type N-glycans in MKN7 and MKN45 stomach cancer cells Biochem. J. 413 2008 227 237
27. S.S. Pinho, C.A. Reis, J. Paredes, A.M. Magalhaes, A.C. Ferreira, J. Figueiredo, W. Xiaogang, F. Carneiro, F. Gartner, and R. Seruca The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin Hum. Mol. Genet. 18 2009 2599 2608
28. Y. Zhao, T. Nakagawa, S. Itoh, K. Inamori, T. Isaji, Y. Kariya, A. Kondo, E. Miyoshi, K. Miyazaki, N. Kawasaki, N. Taniguchi, and J. Gu N-acetylglucosaminyltransferase III antagonizes the effect of N-acetylglucosaminyltransferase V on alpha3beta1 integrin-mediated cell migration J. Biol. Chem. 281 2006 32122 32130
29. M.R. Kudelka, T. Ju, J. Heimburg-Molinaro, and R.D. Cummings Simple sugars to complex disease - mucin-type O-glycans in cancer Adv. Cancer Res. 126 2015 53 135
30. Y. Rossez, E. Maes, T. Lefebvre Darroman, P. Gosset, C. Ecobichon, M. Joncquel Chevalier Curt, I.G. Boneca, J.C. Michalski, and C. Robbe-Masselot Almost all human gastric mucin O-glycans harbor blood group A, B or H antigens and are potential binding sites for Helicobacter pylori Glycobiology 22 2012 1193 1206
31. C. Boccaccio, and P.M. Comoglio Invasive growth: a MET-driven genetic programme for cancer and stem cells Nat. Rev. Cancer 6 2006 637 645
32. N. Beauchemin, and A. Arabzadeh Carcinoembryonic antigen-related cell adhesion molecules (CEACAMs) in cancer progression and metastasis Cancer Metastasis Rev. 32 2013 643 671
33. J.S. Desgrosellier, and D.A. Cheresh Integrins in cancer: biological implications and therapeutic opportunities Nat. Rev. Cancer 10 2010 9 22
34. M.H. Wang, W. Lee, Y.L. Luo, M.T. Weis, and H.P. Yao Altered expression of the RON receptor tyrosine kinase in various epithelial cancers and its contribution to tumourigenic phenotypes in thyroid cancer cells J. Pathol. 213 2007 402 411
35. M.N. Thobe, D. Gurusamy, P. Pathrose, and S.E. Waltz The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells Oncogene 29 2010 214 226
36. J. Logan-Collins, R.M. Thomas, P. Yu, D. Jaquish, E. Mose, R. French, W. Stuart, R. McClaine, B. Aronow, R.M. Hoffman, S.E. Waltz, and A.M. Lowy Silencing of RON receptor signaling promotes apoptosis and gemcitabine sensitivity in pancreatic cancers Cancer Res. 70 2010 1130 1140
37. R.J. McClaine, A.M. Marshall, P.K. Wagh, and S.E. Waltz Ron receptor tyrosine kinase activation confers resistance to tamoxifen in breast cancer cell lines Neoplasia 12 2010 650 658
38. D.V. Catenacci, G. Cervantes, S. Yala, E.A. Nelson, E. El-Hashani, R. Kanteti, M. El Dinali, R. Hasina, J. Bragelmann, T. Seiwert, M. Sanicola, L. Henderson, T.A. Grushko, O. Olopade, T. Karrison, Y.J. Bang, W.H. Kim, M. Tretiakova, E. Vokes, D.A. Frank, H.L. Kindler, H. Huet, and R. Salgia RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma Cancer Biol. Ther. 12 2011 9 46
39. C. Collesi, M.M. Santoro, G. Gaudino, and P.M. Comoglio A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype Mol. Cell. Biol. 16 1996 5518 5526
40. M.M. Santoro, C. Collesi, S. Grisendi, G. Gaudino, and P.M. Comoglio Constitutive activation of the RON gene promotes invasive growth but not transformation Mol. Cell. Biol. 16 1996 7072 7083
41. M. Amado, F. Carneiro, M. Seixas, H. Clausen, and M. Sobrinho-Simoes Dimeric sialyl-Le(x) expression in gastric carcinoma correlates with venous invasion and poor outcome Gastroenterology 114 1998 462 470
42. R. Kannagi Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer Glycoconj. J. 14 1997 577 584
43. S. Nakamori, M. Kameyama, S. Imaoka, H. Furukawa, O. Ishikawa, Y. Sasaki, Y. Izumi, and T. Irimura Involvement of carbohydrate antigen sialyl Lewis(x) in colorectal cancer metastasis Dis. Colon Rectum 40 1997 420 431
44. M. Tatsumi, A. Watanabe, H. Sawada, Y. Yamada, Y. Shino, and H. Nakano Immunohistochemical expression of the sialyl Lewis x antigen on gastric cancer cells correlates with the presence of liver metastasis Clin. Exp. Metastasis 16 1998 743 750
45. S.E. Baldus, T.K. Zirbes, S.P. Monig, S. Engel, E. Monaca, K. Rafiqpoor, F.G. Hanisch, C. Hanski, J. Thiele, H. Pichlmaier, and H.P. Dienes Histopathological subtypes and prognosis of gastric cancer are correlated with the expression of mucin-associated sialylated antigens: sialosyl-Lewis(a), sialosyl-Lewis(x) and sialosyl-Tn Tumour Biol. 19 1998 445 453
46. M. Perez-Garay, B. Arteta, E. Llop, L. Cobler, L. Pages, R. Ortiz, M.J. Ferri, C. de Bolos, J. Figueras, R. de Llorens, F. Vidal-Vanaclocha, and R. Peracaula alpha2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues Int. J. Biochem. Cell Biol. 45 2013 1748-1757
47. Y.J. Kim, and A. Varki Perspectives on the significance of altered glycosylation of glycoproteins in cancer Glycoconj. J. 14 1997 569 576
48. F. Dall'Olio, and M. Chiricolo Sialyltransferases in cancer Glycoconj. J. 18 2001 841 850
49. S. Lin, W. Kemmner, S. Grigull, and P.M. Schlag Cell surface alpha 2,6 sialylation affects adhesion of breast carcinoma cells Exp. Cell Res. 276 2002 101 110
50. H. Yamamoto, A. Oviedo, C. Sweeley, T. Saito, and J.R. Moskal Alpha2,6-sialylation of cell-surface N-glycans inhibits glioma formation in vivo Cancer Res. 61 2001 6822 6829
51. M. Chiricolo, N. Malagolini, S. Bonfiglioli, and F. Dall'Olio Phenotypic changes induced by expression of beta-galactoside alpha2,6 sialyltransferase I in the human colon cancer cell line SW948 Glycobiology 16 2006 146 154
52. R. Kornfeld, and S. Kornfeld Assembly of asparagine-linked oligosaccharides Annu. Rev. Biochem. 54 1985 631 664
53. N. Taniguchi, and Y. Ihara Recent progress in the molecular biology of the cloned N-acetylglucosaminyltransferases Glycoconj. J. 12 1995 733 738
54. S. Kellokumpu, R. Sormunen, and I. Kellokumpu Abnormal glycosylation and altered Golgi structure in colorectal cancer: dependence on intra-Golgi pH FEBS Lett. 516 2002 217 224
55. Y. Song, J.A. Aglipay, J.D. Bernstein, S. Goswami, and P. Stanley The bisecting GlcNAc on N-glycans inhibits growth factor signaling and retards mammary tumor progression Cancer Res. 70 2010 3361 3371
56. S.S. Pinho, P. Oliveira, J. Cabral, S. Carvalho, D. Huntsman, F. Gartner, R. Seruca, C.A. Reis, and C. Oliveira Loss and recovery of Mgat3 and GnT-III Mediated E-cadherin N-glycosylation is a mechanism involved in epithelial-mesenchymal-epithelial transitions PLoS One 7 2012 e33191
57. S. Hakomori Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens Adv. Cancer Res. 52 1989 257 331
58. P.H. Jensen, N.G. Karlsson, D. Kolarich, and N.H. Packer Structural analysis of N- and O-glycans released from glycoproteins Nat. Protoc. 7 2012 1299 1310
59. D. Kolarich, M. Windwarder, K. Alagesan, and F. Altmann Isomer-specific analysis of released N-glycans by LC-ESI MS/MS with porous graphitized carbon Methods Mol. Biol. 1321 2015 427 435
60. C. Slawson, and G.W. Hart O-GlcNAc signalling: implications for cancer cell biology Nat. Rev. Cancer 11 2011 678 684
61. F. Alisson-Silva, L. Freire-de-Lima, J.L. Donadio, M.C. Lucena, L. Penha, J.N. Sa-Diniz, W.B. Dias, and A.R. Todeschini Increase of O-glycosylated oncofetal fibronectin in high glucose-induced epithelial-mesenchymal transition of cultured human epithelial cells PLoS One 8 2013 e60471
62. S. Olivier-Van Stichelen, C. Guinez, A.M. Mir, Y. Perez-Cervera, C. Liu, J.C. Michalski, and T. Lefebvre The hexosamine biosynthetic pathway and O-GlcNAcylation drive the expression of beta-catenin and cell proliferation Am. J. Physiol. Endocrinol. Metab. 302 2012 E417 E424
63. Z. Ma, D.J. Vocadlo, and K. Vosseller Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-kappaB activity in pancreatic cancer cells J. Biol. Chem. 288 2013 15121 15130
64. P. Stanley Golgi Glycosylation, Cold Spring Harbor Perspectives In Biology, 3 2011
65. J. Gu, and N. Taniguchi Regulation of integrin functions by N-glycans Glycoconj. J. 21 2004 9 15
66. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
67. K. Kaszuba, M. Grzybek, A. Orlowski, R. Danne, T. Rog, K. Simons, U. Coskun, and I. Vattulainen N-Glycosylation as determinant of epidermal growth factor receptor conformation in membranes Proc. Natl. Acad. Sci. U. S. A. 112 2015 4334 4339
68. A. Cazet, S. Julien, M. Bobowski, J. Burchell, and P. Delannoy Tumour-associated carbohydrate antigens in breast cancer Breast Cancer Res. 12 2010 204
69. T.K. Choueiri, U. Vaishampayan, J.E. Rosenberg, T.F. Logan, A.L. Harzstark, R.M. Bukowski, B.I. Rini, S. Srinivas, M.N. Stein, L.M. Adams, L.H. Ottesen, K.H. Laubscher, L. Sherman, D.F. McDermott, N.B. Haas, K.T. Flaherty, R. Ross, P. Eisenberg, P.S. Meltzer, M.J. Merino, D.P. Bottaro, W.M. Linehan, and R. Srinivasan Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma J. Clin. Oncol. 31 2013 181 186
70. A. Belalcazar, D. Azana, C.A. Perez, L.E. Raez, and E.S. Santos Targeting the Met pathway in lung cancer Expert. Rev. Anticancer. Ther. 12 2012 519 528
71. Y. Zhang, P.J. Kaplan-Lefko, K. Rex, Y. Yang, J. Moriguchi, T. Osgood, B. Mattson, A. Coxon, M. Reese, T.S. Kim, J. Lin, A. Chen, T.L. Burgess, and I. Dussault Identification of a novel recepteur d'origine nantais/c-met small-molecule kinase inhibitor with antitumor activity in vivo Cancer Res. 68 2008 6680 6687
72. S. Sharma, J.Y. Zeng, C.M. Zhuang, Y.Q. Zhou, H.P. Yao, X. Hu, R. Zhang, and M.H. Wang Small-molecule inhibitor BMS-777607 induces breast cancer cell polyploidy with increased resistance to cytotoxic chemotherapy agents Mol. Cancer Ther. 12 2013 725 736
73. B.S. Pan, G.K. Chan, M. Chenard, A. Chi, L.J. Davis, S.V. Deshmukh, J.B. Gibbs, S. Gil, G. Hang, H. Hatch, J.P. Jewell, I. Kariv, J.D. Katz, K. Kunii, W. Lu, B.A. Lutterbach, C.P. Paweletz, X. Qu, J.F. Reilly, A.A. Szewczak, Q. Zeng, N.E. Kohl, and C.J. Dinsmore MK-2461, a novel multitargeted kinase inhibitor, preferentially inhibits the activated c-Met receptor Cancer Res. 70 2010 1524 1533
74. A.B. Northrup, M.H. Katcher, M.D. Altman, M. Chenard, M.H. Daniels, S.V. Deshmukh, D. Falcone, D.J. Guerin, H. Hatch, C. Li, W. Lu, B. Lutterbach, T.J. Allison, S.B. Patel, J.F. Reilly, M. Reutershan, K.W. Rickert, C. Rosenstein, S.M. Soisson, A.A. Szewczak, D. Walker, K. Wilson, J.R. Young, B.S. Pan, and C.J. Dinsmore Discovery of 1-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide (MK-8033): a specific c-Met/Ron dual kinase inhibitor with preferential affinity for the activated state of c-Met J. Med. Chem. 56 2013 2294 2310
75. J.M. O'Toole, K.E. Rabenau, K. Burns, D. Lu, V. Mangalampalli, P. Balderes, N. Covino, R. Bassi, M. Prewett, K.J. Gottfredsen, M.N. Thobe, Y. Cheng, Y. Li, D.J. Hicklin, Z. Zhu, S.E. Waltz, M.J. Hayman, D.L. Ludwig, and D.S. Pereira Therapeutic implications of a human neutralizing antibody to the macrophage-stimulating protein receptor tyrosine kinase (RON), a c-MET family member Cancer Res. 66 2006 9162 9170
76. Z. Gunes, A. Zucconi, M. Cioce, A. Meola, M. Pezzanera, S. Acali, I. Zampaglione, V. De Pratti, L. Bova, F. Talamo, A. Demartis, P. Monaci, N. La Monica, G. Ciliberto, and A. Vitelli Isolation of fully human antagonistic RON antibodies showing efficient block of downstream signaling and cell migration Transl. Oncol. 4 2011 38 46
77. Q. Ma, K. Zhang, S. Guin, Y.Q. Zhou, and M.H. Wang Deletion or insertion in the first immunoglobulin-plexin-transcription (IPT) domain differentially regulates expression and tumorigenic activities of RON receptor tyrosine kinase Mol. Cancer 9 2010 307
78. M. Ingelman-Sundberg Personalized medicine into the next generation J. Intern. Med. 277 2015 152 154
79. T. Tursz, and R. Bernards Hurdles on the road to personalized medicine Mol. Oncol. 9 2015 935 939
80. N. Shibuya, I.J. Goldstein, W.F. Broekaert, M. Nsimba-Lubaki, B. Peeters, and W.J. Peumans The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(alpha 2-6)Gal/GalNAc sequence J. Biol. Chem. 262 1987 1596 1601